产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
McCoy's 5A培养基是Thomas McCoy等人在1959年设计的培养基,最初专门用于Novikoff Hepatoma细胞的培养。McCoy's 5A培养基是改良的Basal Medium 5A,与其他培养基不同的是,McCoy's 5A含有还原型谷胱甘肽、细菌蛋白胨以及高浓度的葡萄糖。McCoy's 5A广泛用于多种类型的原代细胞的培养,如骨髓、皮肤、牙龈、肾、脾、肺、大鼠胚胎、网膜等。此外McCoy's 5A培养基还用于组织活检培养、细胞建系,以及一些淋巴细胞和较难培养的细胞的培养。
本产品含有多类细胞培养所需的氨基酸、维生素、无机盐等多种成分,但不含蛋白质、脂类或任何生长因子,故此产品需搭配血清或无血清添加物使用。
成分说明
形态 | 液体 |
浓度 | 1× |
规格 | 500mL |
PH | 7.2~7.4 |
L-谷氨酰胺 | 1.5mM |
NaHCO3 | 2200mg/L |
D-葡萄糖 | 3000mg/L |
HEPES缓冲剂 | 无 |
酚红指示剂 | 10mg/L |
储存条件 | 2~8℃,避光 |
运输条件 | 常温 |
有效期 | 12个月 |
注意事项
1、本产品经过滤除菌,使用时应注意无菌操作,避免污染;
2、为保持本产品的最佳使用效果,请勿进行冻融处理;
3、本产品仅用于科研或进一步研究使用,不用于诊断和治疗。
参考文献
-
Nitroreductase-instructed supramolecular assemblies for microbiome regulation to enhance colorectal cancer treatments(2022/11/09)
作者:Jiali Chen, Pai Zhang, Yan Zhao, Jie Zhao, Xiaobo Wu, Ruijia Zhang, Ruitao Cha, Qingxin Yao, Yuan Gao
期刊:Science Advances
影响因子 :14.9570
引用产品:CL-0071 CL-0096 CL-0101 CL-0118 PM150110 PM150210 PM150710
-
Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis(2023/02/14)
作者:Fuli Shi, Lisha Yuan, Taksui Wong
期刊:PHARMACOLOGICAL RESEARCH
DOI:10.1016/j.phrs.2023.106697
影响因子 :10.3340
引用产品:PM150710
-
WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity(2023/01/07)
作者:Xiaosong Wei, Beibei Wang, Zixin Wu
期刊:CANCER LETTERS
DOI:10.1016/j.canlet.2023.216058
影响因子 :9.7560
引用产品:CL-0002 CL-0125 CL-0222 CL-0227 CL-0449A CL-0463 CL-0628 PM150410 PM150710 PM150910 PM151010
-
A possible but unrecognized risk of acceptable daily intake dose triazole pesticides exposure—bile acid disturbance induced pharmacokinetic changes of oral medication(2023/02/21)
作者:Yujing Xu, Yufeng Zhang, Quan Tao
期刊:CHEMOSPHERE
DOI:10.1016/j.chemosphere.2023.138209
影响因子 :8.9430
-
Aa-Z2 triggers ROS-induced apoptosis of osteosarcoma by targeting PDK-1(2023/01/07)
作者:Yixin Liu, Wenyan She, Yi Li
期刊:Journal of Translational Medicine
DOI:10.1186/s12967-022-03862-1
影响因子 :8.4400
-
Chiral Analysis of Lactate during Direct Contact Coculture by Single-Cell On-Probe Enzymatic Dehydrogenation Derivatization: Unraveling Metabolic Changes Caused by d-Lactate(2021/03/16)
作者:Yuling Li, Bowen Zhou, Yuqi Cao
期刊:Anal Chem
DOI:10.1021/acs.analchem.0c05015
影响因子 :8.008
-
Chlorophyllin Inhibits Mammalian Thioredoxin Reductase 1 and Triggers Cancer Cell Death(2021/10/29)
作者:Shibo Sun, Yici Zhang, Weiping Xu
期刊:Antioxidants
影响因子 :7.675
-
Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3(2022/09/24)
作者:Tianyi Shen, Suqin Miao, Yulin Zhou
期刊:Cell Communication and Signaling
DOI:10.1186/s12964-022-00957-6
影响因子 :7.5250
引用产品:PM150710
-
Isothiocyanate Iberin inhibits cell proliferation and induces cell apoptosis in the progression of ovarian cancer by mediating ROS accumulation and GPX1 expression(2021/06/17)
作者:Tingting Gong, Qian Guo, Xiao Li
期刊:Biomedicine & Pharmacotherapy
DOI:10.1016/j.biopha.2021.111533
影响因子 :7.419
-
Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action(2022/10/31)
作者:Zukela Ruzi, Khurshed Bozorov, Lifei Nie
期刊:BIOMEDICINE & PHARMACOTHERAPY
DOI:10.1016/j.biopha.2022.113948
影响因子 :7.4190
引用产品:PM150710
-
PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/β-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib(2022/09/05)
作者:Xiaocui Zhang, Meige Sun, Yisheng Jiao
期刊:Oxidative Medicine and Cellular Longevity
影响因子 :7.3100
引用产品:164210 164210-50 CL-0013 CL-0079 CL-0178 P-CA-161 PM150110 PM150710
-
Photothermal Nanoheaters-Modified Spores for Safe and Controllable Antitumor Therapy(2022/12/15)
作者:Xin Zhang, Yang Zhang, Ning Wang
期刊:International Journal of Nanomedicine
影响因子 :7.0330
引用产品:PM150710
-
Comprehensive Pan-Cancer Analyses of Immunogenic Cell Death as a Biomarker in Predicting Prognosis and Therapeutic Response(2022/12/01)
作者:Yuan Wang, Yongbiao Huang, Mu Yang
期刊:Cancers
影响因子 :6.5750
引用产品:PM150710
-
Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway(2021/06/18)
作者:Jiangtao Fan, Zhaoyu Zhou, Yanlu Luo
期刊:Neoplasia
影响因子 :6.218
-
Nigericin exerts anticancer effects through inhibition of the SRC/STAT3/BCL-2 in osteosarcoma(2022/01/31)
作者:Zhiqiang Yang, Jiangtao Xie, Jiayu Fang
期刊:Biochemical Pharmacology
影响因子 :6.1000
引用产品:PM150710
-
PYY modulates the tumorigenesis and progression of colorectal cancer unveiled by proteomics(2022/12/15)
作者:Fangyan Jing, Guanglong Liu, Renyi Zhang
期刊:American Journal of Cancer Research
DOI:PMID:36628274
影响因子 :5.9420
引用产品:PM150710
-
A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma.(2022/11/11)
作者:Xinxing Wang, Guang Xia, Shilang Xiao, Song Wu, Lina Zhang, Junjie Huang, Wenxiu Zhang, Xu Cao, Image_1.tif, Image_2.tif, Image_3.tif, Image_4.tif, Image_5.tif, Image_6.tif, Image_7.tif, DataSheet_1.csv, DataSheet_2.csv, DataSheet_3.csv, DataSheet_4.
期刊:Frontiers in Oncology
影响因子 :5.7380
-
NPR3, transcriptionally regulated by POU2F1, inhibits osteosarcoma cell growth through blocking the PI3K/AKT pathway(2021/7/3)
作者:Shuo Li, Ruirong Guo, Zhibin Peng
期刊:Cellular Signalling
DOI:10.1016/j.cellsig.2021.110074
影响因子 :4.8500
-
Upregulated X-C motif chemokine ligand 2 (XCL2) is associated with poor prognosis and increased immune infiltration in clear cell renal cell carcinoma(2022/12/09)
作者:Qingqiong Cao, Daoquan Liu, Zhao Chen
期刊:CELLULAR SIGNALLING
DOI:10.1016/j.cellsig.2022.110556
影响因子 :4.8500
引用产品:PM150710
-
FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis(2022/09/16)
作者:Xing Huang, Tao Wang, Jiali Ye
期刊:Frontiers in Genetics
影响因子 :4.7720
-
Characterization of the SARS-CoV-2 co-receptor NRP1 expression profiles in healthy people and cancer patients: Implication for susceptibility to COVID-19 disease and potential therapeutic strategy(2022/10/19)
作者:Yongbiao Huang, Yuan Wang, Duo Xu
期刊:Frontiers in Genetics
影响因子 :4.7720
引用产品:PM150710
-
Synthesis and anticancer activity of ethyl 5-amino-1-N-substituted-imidazole-4-carboxylate building blocks(2021/05/25)
作者:Zukela Ruzi, Lifei Nie, Khurshed Bozorov
期刊:Archiv Der Pharmazie
影响因子 :4.613
引用产品:PM150710
-
A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma(2022/12/10)
作者:Kenan Zhang, Wuping Yang, Zedan Zhang
期刊:Journal of Oncology
影响因子 :4.5010
-
Up-Regulation of SH3TC2 Induced by YTHDF1 Predicts Poor Outcome and Facilitates Cell-Cycle Progress in Colorectal Cancer(2022/12/15)
作者:Huili Wu, Feifei Chu, Lu Li
期刊:Journal of Oncology
影响因子 :4.5010
-
Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription(2022/08/14)
作者:Yu Zhong, Ouyang Ling
期刊:Human Cell
DOI:10.1007/s13577-022-00767-5
影响因子 :4.3740
引用产品:PM150710
-
Fatty Acid–Binding Protein 4 (FABP4) Suppresses Proliferation and Migration of Endometrial Cancer Cells via PI3K/Akt Pathway(2021/06/29)
作者:Zimeng Wu, Ji-Hak Jeong, Chenchen Ren
期刊:OncoTargets and Therapy
影响因子 :4.3450
-
Circular RNA circ_0007142 Facilitates Colorectal Cancer Progression by Modulating CDC25A Expression via miR-122-5p(2020/5/1)
作者:Wenzhe Yin, Jun Xu, Chao Li
期刊:OncoTargets and Therapy
影响因子 :4.3450
引用产品:PM150710
-
OSU-03012 Disrupts Akt Signaling and Prevents Endometrial Carcinoma Progression in vitro and in vivo(2021/04/30)
作者:Leilei Ding, Chenchen Ren, Li Yang
期刊:Drug Design Development and Therapy
影响因子 :4.3190
-
The potential of Lycium barbarum miR166a in kidney cancer treatment(2022/12/28)
作者:Qiang Zhang, Zhiyuan Xie, Yan Li
期刊:EXPERIMENTAL CELL RESEARCH
DOI:10.1016/j.yexcr.2022.113455
影响因子 :4.1450
-
GBP2 promotes clear cell renal cell carcinoma progression through immune infiltration and regulation of PD‑L1 expression via STAT1 signaling(2023/01/20)
作者:Shujiang Ye, Siyu Li, Lei Qin
期刊:ONCOLOGY REPORTS
影响因子 :4.1360
-
LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway(2023/02/10)
作者:Sijia Han, Xueying Jin, Tianyu Hu, Feng Chi
期刊:ONCOLOGY REPORTS
影响因子 :4.1360
-
Long-Lasting Proteinaceous Nanoformulation for Tumor Imaging and Therapy(2022/08/24)
作者:Lai Zhao, Xinquan Gu, Fuquan Jiang
期刊:ACS Omega
影响因子 :4.1320
-
Circ_0056618 enhances PRRG4 expression by competitively binding to miR-411-5p to promote the malignant progression of colorectal cancer(2022/08/02)
作者:Bo Zhang, Wenbin Cao, Yang Liu
期刊:MOLECULAR AND CELLULAR BIOCHEMISTRY
DOI:10.1007/s11010-022-04525-x
影响因子 :3.8420
-
Circular RNA pyridoxal kinase (circPDXK) involves in the progression of ovarian cancer and glycolysis via regulating miR-654-3p and hexokinase II(2022/12/06)
作者:Lijuan Hou, Wenwen Wang, Jianjun Zhai
期刊:Applied Biological Chemistry
DOI:10.1186/s13765-022-00747-1
影响因子 :3.2060
引用产品:PM150710
-
Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study(2023/01/09)
作者:Weibo Dai, Jing Yang, Xin Liu
期刊:BMC Complementary Medicine and Therapies
DOI:10.1186/s12906-022-03822-8
影响因子 :2.8380
引用产品:PM150710
-
microRNA-4429-5p suppresses the malignant development of colon cancer by targeting matrix metalloproteinase 16(2021/08/26)
作者:Wei Li, Zhe Song, Nan Jia
期刊:In Vitro Cellular & Developmental Biology-Animal
DOI:10.1007/s11626-021-00603-4
影响因子 :2.7230